Home/ Supplements/ Omega 3/ Prenatal DHA/EPA Supplement

Prenatal DHA/EPA Supplement

product on market Softgel Capsule up&up Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Omega-3 fatty acids, including DHA and EPA, are supported by strong evidence for supporting fetal brain and visual development during pregnancy. Cholesterol serves as a structural component of cell membranes. Current research indicates these ingredients are generally safe for prenatal use.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Prenatal DHA/EPA Supplement
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
Fat/Fatty Acid
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Cholesterol
10 mg
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Fish Oil Gelatin Glycerin Ethylcellulose Ammonium Hydroxide Medium Chain Triglycerides Oleic Acid Sodium Alginate Mixed Tocopherols Stearic Acid
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Directions: Adults: One softgel daily, with food.

Warnings & Precautions

Contains: Sardines, Anchovies, Soy

Caution: If you are pregnant, inform your doctor, or if nursing, your child's doctor, that you are taking this product. Ask your doctor before use if you are taking any medication, planning any medical procedure, have a medical condition or have bleeding problems.

Keep out of reach of children.

Do not use if printed seal under cap is broken or missing

Formulation Notes

Gluten free

Additional Information

Store at room temperature. Avoid excessive heat.

Questions? Call 1-888-547-7400

Made in Cananda

Metadata

Product Details

DSLD Entry Date2020-01-25
Product TypeFat/Fatty Acid
FormSoftgel Capsule
Brandup&up
DSLD ID211613
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.